Pilot Study on Improving Mobility and Universal Accessibility for Individuals With Visual Disabil… (NCT06602102) | Clinical Trial Compass
CompletedNot Applicable
Pilot Study on Improving Mobility and Universal Accessibility for Individuals With Visual Disabilities in Barcelona
Spain41 participantsStarted 2024-10-22
Plain-language summary
The project BCNMob informs about a research study approved by the Ethics Committee of the Hospital Universitario Mútua Terrassa
The study aims to improve the Biel Glasses virtual reality glasses to assist patients with low vision in detecting and locating objects during mobility. Optometric evaluations and training sessions will be conducted, followed by tests in an urban environment in Barcelona.
There are no significant risks associated with participation, although mild discomfort may arise. The information collected will be confidential and managed according to data protection legislation. No financial compensation will be offered.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria:
* Minimum age of 18 years.
* Patients with peripheral vision (PV) \<20º in both eyes, and the patient expresses difficulty in their ability to move independently and safely in everyday environments.
* Distant visual acuity with the best possible correction in the better eye (VA) ≤ 0.3 (30%) and who expresses problems orienting in external environments.
The use of a cane or any other mobility aid is NOT an exclusion criterion.
* Patients with ophthalmological diagnoses: glaucoma, retinitis pigmentosa, Leber congenital amaurosis, high myopia, diabetic retinopathy, and other pathologies that cause hemianopsias.
* Ability to understand and follow the study instructions.
* Physical and cognitive ability to use virtual reality glasses and actively participate in the tests.
* Availability to participate in the study (8 hours on average spread over 3-4 sessions).
* The tests to evaluate the patien\';s visual examination will be conducted at the Centre Universitari de la Visió (CUV) CUV Terrassa: Passeig del Vint-i-dos de Juliol, 660, 08222 Terrassa.
Exclusion criteria:
* Patients who are in active treatment for ocular conditions or who have received recent ophthalmological treatment or have had prior surgery within 3 months before the start of the study tests.
* Patients diagnosed with neurodegenerative diseases.
* Presence of medical or psychological conditions that may interfere with the safe participation in the study.
* Individuals who have…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of obstacles identified in time and avoided
Timeframe: Throughout the testing session with the virtual reality glasses.
2
Walking speed while using virtual reality (VR) glasses
Timeframe: From enrollment to the end of treatment at 2 weeks